In the present study, we used two CSF1R inhibitors with different mechanisms of action to determine the effects of CSF1R inhibition in combination with anti-VEGF therapy in the setting of adaptive resistance in ovarian cancer models. This evidence concerns the gene CSF1R and ovarian carcinoma.